Effects of cannabinoid and glutamate receptor antagonists and their interactions on learning and memory in male rats

被引:37
作者
Barzegar, Somayeh [1 ]
Komaki, Alireza [1 ]
Shahidi, Siamak [1 ]
Sarihi, Abdolrahman [1 ]
Mirazi, Naser [1 ]
Salehi, Iraj [1 ]
机构
[1] Hamadan Univ Med Sci, Neurophysiol Res Ctr, Hamadan, Iran
关键词
Cannabinoid; Glutamate; Memory; Learning; Passive avoidance test; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; SELECTIVE ANTAGONIST; NMDA RECEPTORS; CB1; RECEPTORS; MODULATION; INDUCTION; PLASTICITY; INHIBITION; REVERSAL;
D O I
10.1016/j.pbb.2015.02.005
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Introduction: Despite previous findings on the effects of cannabinoid and glutamatergic systems on learning and memory, the effects of the combined stimulation or the simultaneous inactivation of these two systems on learning and memory have not been studied. In addition, it is not clear whether the effects of the cannabinoid system on learning and memory occur through the modulation of glutamatergic synaptic transmission. Hence, in this study, we examined the effects of the simultaneous inactivation of the cannabinoid and glutamatergic systems on learning and memory using a passive avoidance (PA) test in rats. Materials and methods: On the test day, AM251, which is a CBI cannabinoid receptor antagonist; MK-801, which is a glutamate receptor antagonist; or both substances were injected intraperitoneally into male Wistar rats 30 min before placing the animal in a shuttle box. A learning test (acquisition) was then performed, and a retrieval test was performed the following day. Results: Learning and memory in the PA test were significantly different among the groups. The CBI receptor antagonist improved the scores on the PA acquisition and retention tests. However, the glutamatergic receptor antagonist decreased the acquisition and retrieval scores on the PA task. The CBI receptor antagonist partly decreased the glutamatergic receptor antagonist effects on PA learning and memory. Conclusions: These results indicated that the acute administration of a CBI antagonist improved cognitive performance on a PA task in normal rats and that a glutamate-related mechanism may underlie the antagonism of cannabinoid by AM251 in learning and memory. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:87 / 90
页数:4
相关论文
共 48 条
[41]   Plasticity, hippocampal place cells, and cognitive maps [J].
Shapiro, M .
ARCHIVES OF NEUROLOGY, 2001, 58 (06) :874-881
[42]   Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition [J].
Stumm, Christoph ;
Hiebel, Christof ;
Hanstein, Regina ;
Purrio, Martin ;
Nagel, Heike ;
Conrad, Andrea ;
Lutz, Beat ;
Behl, Christian ;
Clement, Angela B. .
NEUROBIOLOGY OF AGING, 2013, 34 (11) :2574-2584
[43]   Effects of ethanol, Δ9-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats [J].
Swartzwelder, Nicholas A. ;
Risher, M. Louise ;
Abdelwahab, Sabri H. ;
D'Abo, Anouska ;
Rezvani, Amir H. ;
Levin, Edward D. ;
Wilson, Wilkie A. ;
Swartzwelder, H. Scott ;
Acheson, Shawn K. .
NEUROSCIENCE LETTERS, 2012, 527 (01) :11-15
[44]   INHIBITION OF LONG-TERM POTENTIATION IN RAT HIPPOCAMPAL SLICES BY ANANDAMIDE AND WIN55212-2 - REVERSAL BY SR141716-A, A SELECTIVE ANTAGONIST OF CB1 CANNABINOID RECEPTORS [J].
TERRANOVA, JP ;
MICHAUD, JC ;
LEFUR, G ;
SOUBRIE, P .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1995, 352 (05) :576-579
[45]  
Wang XQ, 2014, BR J PHARM
[46]   Hippocampal CB1 Receptors Mediate the Memory Impairing Effects of Δ9-Tetrahydrocannabinol [J].
Wise, Laura E. ;
Thorpe, Andrew J. ;
Lichtman, Aron H. .
NEUROPSYCHOPHARMACOLOGY, 2009, 34 (09) :2072-2080
[47]   Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats:: Role of glutamate in the nucleus accumbens [J].
Xi, Zheng-Xiong ;
Gilbert, Jeremy G. ;
Peng, Xiao-Qing ;
Pak, Arlene C. ;
Li, Xia ;
Gardner, Eliot L. .
JOURNAL OF NEUROSCIENCE, 2006, 26 (33) :8531-8536
[48]   Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores [J].
Zhuang, SY ;
Bridges, D ;
Grigorenko, E ;
McCloud, S ;
Boon, A ;
Hampson, RE ;
Deadwyler, SA .
NEUROPHARMACOLOGY, 2005, 48 (08) :1086-1096